Search

everythinglearnresearchcommunity

for

Search:↓

Genetic variants can affect valproic acid's effectiveness, side effects, and levels in epilepsy treatment.

Dutasteride is more efficient than finasteride, but individual results vary.

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Genetic testing is crucial before giving azathioprine to avoid severe side effects.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

The Rotterdam Study aims to understand various diseases in older adults.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Longer TA repeats in the SRD5A2 gene may increase acne risk in Chinese people.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.